Ask the Doctors May 2010 Issue

Ask The Doctors: May 2010

Analysis of data from a large trial has suggested that there is a slightly increased risk of blood clot formation in the veins, or venous thromboembolism (VTE), in patients taking raloxifene compared to those on placebo. The risk for fatal stroke appears somewhat higher, as well. However, the overall risk of these events is still extremely low. Active smoking was the only cardiovascular risk factor which could be tied to increased chance of fatal stroke while taking raloxifene.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.